0
     

Report Added
Report already added
Asia Pacific Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity

Asia Pacific electrocardiograph (ECG) market will grow by 8.2% annually with a total addressable market cap of $32,834.0 million over 2022-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure.

Highlighted with 31 tables and 57 figures, this 120-page report “Asia Pacific Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Conventional Devices
oResting ECG Devices
oStress ECG Devices
•Emerging Devices
oImplantable Loop Recorders
oMobile Cardiac Telemetry
oHolter Monitors
oCardiac Event Monitors
oSmart ECG Monitors
•Software & Services

Based on Lead Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single-Lead Type ECG Devices
•3-Lead Type ECG Devices
•5-Lead Type ECG Devices
•6-Lead Type ECG Devices
•12-Lead Type ECG Devices
•Other Lead Types

By Function, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Diagnostic ECG Systems
•Monitoring ECG Systems

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Portable ECG Systems
•Wireless ECG Systems

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Hospitals and Clinics
•Ambulatory Surgical Centers (ASCs)
•Home-based Users
•Cardiac Centers
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Lead Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Abbott Laboratories
ACS Diagnostics
Biotricity, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
CardioComm Solutions, Inc.
Cardioline SpA
Edan Instruments, Inc.
Fukuda Denshi Co., Ltd.
General Electric Company
Hill-Rom Holdings, Inc.
iRhythm Technologies, Inc.
Koninklijke Philips N.V.
Medtronic plc
Mindray Medical International Limited
Nihon Kohden Corporation
OSI Systems, Inc.
Schiller AG
Suzuken Co., Ltd.
Zoll Medical Corporation (Asahi Kasei Corporation)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market23
2.2 Major Growth Drivers25
2.3 Market Restraints and Challenges31
2.4 Emerging Opportunities and Market Trends34
2.5 Porter’s Fiver Forces Analysis38
3 Segmentation of Asia Pacific Market by Product Type42
3.1 Market Overview by Product Type42
3.2 Conventional Devices44
3.2.1 Resting ECG Devices45
3.2.2 Stress ECG Devices46
3.3 Emerging Devices47
3.3.1 Implantable Loop Recorders49
3.3.2 Mobile Cardiac Telemetry50
3.3.3 Holter Monitors51
3.3.4 Cardiac Event Monitors52
3.3.5 Smart ECG Monitors53
3.4 Software & Services54
4 Segmentation of Asia Pacific Market by Lead Type55
4.1 Market Overview by Lead Type55
4.2 Single-Lead Type ECG Devices57
4.3 3-Lead Type ECG Devices58
4.4 5-Lead Type ECG Devices59
4.5 6-Lead Type ECG Devices60
4.6 12-Lead Type ECG Devices61
4.7 Other Lead Types62
5 Segmentation of Asia Pacific Market by Function63
5.1 Market Overview by Function63
5.2 Diagnostic ECG Systems65
5.3 Monitoring ECG Systems66
6 Segmentation of Asia Pacific Market by Technology67
6.1 Market Overview by Technology67
6.2 Portable ECG Systems69
6.3 Wireless ECG Systems70
7 Segmentation of Asia Pacific Market by End User71
7.1 Market Overview by End User71
7.2 Hospitals and Clinics73
7.3 Ambulatory Surgical Centers (ASCs)74
7.4 Home-based Users75
7.5 Cardiac Centers76
7.6 Other End Users77
8 Asia-Pacific Market 2021-2031 by Country78
8.1 Overview of Asia-Pacific Market78
8.2 Japan81
8.3 China84
8.4 Australia87
8.5 India89
8.6 South Korea91
8.7 Rest of APAC Region93
9 Competitive Landscape95
9.1 Overview of Key Vendors95
9.2 New Product Launch, Partnership, Investment, and M&A98
9.3 Company Profiles99
Abbott Laboratories99
ACS Diagnostics101
Biotricity, Inc.102
BIOTRONIK SE & Co. KG103
Boston Scientific Corporation104
CardioComm Solutions, Inc.105
Cardioline SpA106
Edan Instruments, Inc.107
Fukuda Denshi Co., Ltd.108
General Electric Company109
Hill-Rom Holdings, Inc.110
iRhythm Technologies, Inc.111
Koninklijke Philips N.V.112
Medtronic plc113
Mindray Medical International Limited114
Nihon Kohden Corporation115
OSI Systems, Inc.116
Schiller AG117
Suzuken Co., Ltd.118
Zoll Medical Corporation (Asahi Kasei Corporation)119
RELATED REPORTS120

List of Tables:

Table 1. Snapshot of Asia Pacific Electrocardiograph Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203122
Table 3. World Health Spending by Region, $ bn, 2013-202030
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Electrocardiograph Market34
Table 5. Asia Pacific Electrocardiograph Market by Product Type, 2021-2031, $ mn42
Table 6. Asia Pacific Electrocardiograph Market: Conventional Devices by Type, 2021-2031, $ mn44
Table 7. Asia Pacific Electrocardiograph Market: Emerging Devices by Type, 2021-2031, $ mn48
Table 8. Asia Pacific Electrocardiograph Market by Lead Type, 2021-2031, $ mn55
Table 9. Asia Pacific Electrocardiograph Market by Function, 2021-2031, $ mn63
Table 10. Asia Pacific Electrocardiograph Market by Technology, 2021-2031, $ mn67
Table 11. Asia Pacific Electrocardiograph Market by End User, 2021-2031, $ mn71
Table 12. APAC Electrocardiograph Market by Country, 2021-2031, $ mn79
Table 13. Japan Electrocardiograph Market by Product Type, 2021-2031, $ mn83
Table 14. Japan Electrocardiograph Market by Lead Type, 2021-2031, $ mn83
Table 15. Japan Electrocardiograph Market by End User, 2021-2031, $ mn83
Table 16. China Electrocardiograph Market by Product Type, 2021-2031, $ mn85
Table 17. China Electrocardiograph Market by Lead Type, 2021-2031, $ mn85
Table 18. China Electrocardiograph Market by End User, 2021-2031, $ mn85
Table 19. Australia Electrocardiograph Market by Product Type, 2021-2031, $ mn88
Table 20. Australia Electrocardiograph Market by Lead Type, 2021-2031, $ mn88
Table 21. Australia Electrocardiograph Market by End User, 2021-2031, $ mn88
Table 22. India Electrocardiograph Market by Product Type, 2021-2031, $ mn90
Table 23. India Electrocardiograph Market by Lead Type, 2021-2031, $ mn90
Table 24. India Electrocardiograph Market by End User, 2021-2031, $ mn90
Table 25. South Korea Electrocardiograph Market by Product Type, 2021-2031, $ mn92
Table 26. South Korea Electrocardiograph Market by Lead Type, 2021-2031, $ mn92
Table 27. South Korea Electrocardiograph Market by End User, 2021-2031, $ mn92
Table 28. Electrocardiograph Market in Rest of APAC by Country/Region, 2021-2031, $ mn94
Table 29. Abbott Laboratories: Company Snapshot99
Table 30. Abbott Laboratories: Business Segmentation100
Table 31. Abbott Laboratories: Product Portfolio100

Report Title: Asia Pacific Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline